Ultrasonography in Norwegian Emergency Department Patients With Suspected Covid-19 Infection
- Conditions
- COVID-19Pulmonary InfectionPneumonia, Viral
- Interventions
- Diagnostic Test: Lung ultrasound
- Registration Number
- NCT04422691
- Lead Sponsor
- St. Olavs Hospital
- Brief Summary
In light of the ongoing COVID-19 epidemic in Norway, it is paramount to develop and utilize clinical tools for assessing and risk stratifying patients with suspected coronary infection in the emergency departments. Diagnostic use of ultrasound in viral pneumonias, including COVID-19 has proved to be very useful. The use of ultrasound will assist in quick detection of lung pathology compatible with increasing severity of the COVID-19 disease. At the same time, the use of ultrasound diagnostics in the emergency department could improve logistics and reduce potential exposure of the corona virus to other health personnel.
The purpose of the study is to assess whether ultrasound findings correlates with physical examination, labs, and other imaging diagnostics in patients with suspected or diagnosed COVID-19 disease, as well as assessing whether ultrasound diagnostics can assist in risk stratification. The project is conducted as a prospective multicenter study where ultrasound diagnostics will be performed on patients with suspected coronary infection in the emergency departments. Data collection takes place as part of the daily clinical evaluation of acute patients in the emergency departments. The project is planned to be completed towards the end of 2025.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 5
- All emergency department patients with suspected or diagnosed COVID-19.
- Negative screening for COVID-19
- recent negative COVID-19 test
- no indication for isolation in the Emergency Department
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Covid-19 suspected Lung ultrasound Emergency department patients with suspected or diagnosed COVID-19 disease. All patients will be screened at triage and put into isolation if suspected disease. Ultrasound of the patients lungs will be performed after patient consent and findings will be recorded and categorized (Soldati et al., 2020). The use of ultrasound and registration of data will not affect the regular patient evaluation, treatment or logistics.
- Primary Outcome Measures
Name Time Method Level-of-care up to 7 days In-hospital treatment level, e.g. discharge from ED, observational unit, ward, ICU.
Mortality up to 30 days 30-day mortality
- Secondary Outcome Measures
Name Time Method Oxygen usage in the emergency department Within 24 hours Emergency department length of stay Within 24 hours in hours
In-hospital length of stay Up to 30 days in days
Antibiotics usage Within 24 hours
Trial Locations
- Locations (9)
Sørlandet sykehus, Kristiansand
🇳🇴Kristiansand, Norway
Ullevål University Hospital
🇳🇴Oslo, Norway
Sykehuset Telemark HF
🇳🇴Skien, Norway
St Olavs Hospital
🇳🇴Trondheim, Norway
Nordland Hospital
🇳🇴Bodø, Norway
Akershus University Hospital
🇳🇴Oslo, Norway
Stavanger Universitetssjukehus
🇳🇴Stavanger, Norway
Drammen sykehus
🇳🇴Drammen, Norway
Haukeland universitetssykehus
🇳🇴Bergen, Norway